PHASE-I TRIAL OF PALA (N-PHOSPHONACETYL-L-ASPARTATE)

被引:0
|
作者
ERLICHMAN, C [1 ]
STRONG, J [1 ]
WIERNIK, P [1 ]
EDWARDS, L [1 ]
COHEN, M [1 ]
LEVINE, A [1 ]
HUBBARD, S [1 ]
CHABNER, B [1 ]
机构
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:314 / 314
页数:1
相关论文
共 50 条
  • [1] N-PHOSPHONACETYL-L-ASPARTATE (PALA), PHASE-I TRIAL
    ERVIN, TJ
    BLUM, RH
    CANELLOS, GP
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 200 - 200
  • [2] A PHASE-I TRIAL OF COMBINED THERAPY WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5-FU)
    MESHAD, MW
    ERVIN, TJ
    JOHNSON, RK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 341 - 341
  • [3] PHASE I-II TRIAL OF N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5FU)
    ERLICHMAN, C
    DONEHOWER, RC
    KLECKER, R
    CHABNER, BA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 366 - 366
  • [4] PHASE-I TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE
    ERLICHMAN, C
    STRONG, JM
    WIERNIK, PH
    MCAVOY, LM
    COHEN, MH
    LEVINE, AS
    HUBBARD, SM
    CHABNER, BA
    [J]. CANCER RESEARCH, 1979, 39 (10) : 3992 - 3995
  • [5] PHASE-I TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)
    ERVIN, TJ
    BLUM, RH
    MESHAD, MW
    KUFE, DW
    JOHNSON, RK
    CANELLOS, GP
    [J]. CANCER TREATMENT REPORTS, 1980, 64 (10-1): : 1067 - 1071
  • [6] COMPETITIVE PROTEIN-BINDING ASSAY FOR N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    ERLICHMAN, C
    CHABNER, BA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 185 - 185
  • [7] PHASE-I TRIAL OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), METHOTREXATE (MTX), 5-FLUOROURACIL (FU), AND LEUCOVORIN (LV) IN ADVANCED COLORECTAL-CANCER (CRC)
    KEMENY, N
    REICHMAN, B
    GORDON, C
    ELLISON, S
    DEONARINE, S
    SLAVIK, B
    MARTIN, D
    YOUNG, C
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 187 - 187
  • [8] BIOCHEMICAL ASPECTS OF CHEMOTHERAPY OF MOUSE NEOPLASMS WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    BROCKMAN, RW
    ROSE, LM
    SHADDIX, SC
    DUBOIS, NF
    SCHABEL, FM
    [J]. FEDERATION PROCEEDINGS, 1978, 37 (06) : 1693 - 1693
  • [9] AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), A NEW ANTIMETABOLITE
    ERLICHMAN, C
    [J]. RECENT RESULTS IN CANCER RESEARCH, 1980, 74 : 65 - 71
  • [10] Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside
    Hageboutros, A
    Hudes, GR
    Brennan, J
    Green, F
    Hoffman, J
    LaCreta, FP
    Colofiore, J
    Martin, DS
    Ozols, RF
    ODwyer, PJ
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (03) : 229 - 234